Welcome to our dedicated page for CHS SEC filings (Ticker: CHSCM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CHS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CHS's regulatory disclosures and financial reporting.
CHS Inc. reported a second quarter fiscal 2026 net loss of $147.1 million on revenues of $8.4 billion, compared with a net loss of $75.8 million and revenues of $7.8 billion a year earlier, reflecting wider losses despite higher sales.
The energy segment posted a pretax loss of $133.6 million, a larger loss than the prior year period, driven by significantly higher renewable energy credit expenses and hedging losses, partly offset by better crack spreads and refined fuels mix. Grains recorded a pretax loss of $17.9 million and agronomy a pretax loss of $11.5 million, both slightly worse than the prior year, as weaker oilseed crush and crop nutrient margins outweighed benefits from corn exports and the CF Nitrogen joint venture.
Corporate and Services moved to a pretax loss of $1.9 million from prior-year income, mainly due to lower equity method earnings from joint ventures. For the first six months of fiscal 2026, CHS reported income before income taxes of $107.2 million and net income attributable to CHS Inc. of $113.4 million, both below the prior year’s six-month results.
CHS Inc. reported a larger quarterly loss as margins tightened across its cooperative agribusiness. For the three months ended February 28, 2026, revenues were $8,353,791,000, up modestly from $7,796,191,000, but net loss attributable to CHS widened to $147,052,000 from $75,754,000.
Gross profit for the quarter dropped to $25,818,000 from $76,315,000, and operating loss deepened to $241,791,000, reflecting higher cost of goods sold and increased marketing, general and administrative expenses. Interest expense also rose sharply to $43,757,000, driven by higher debt levels and rates.
For the six months, revenues were essentially flat at $17,217,895,000 versus $17,090,303,000, while net income attributable to CHS declined to $113,431,000 from $169,036,000. Cash flow from operating activities remained negative at $(906,831,000), though improved versus the prior year’s outflow. Total assets increased to $20,908,534,000, supported by higher inventories and receivables, while notes payable and long-term debt together rose to over $4,115,000,000.
CHS Inc. declared regular quarterly dividends on five series of its preferred stock. The company set per-share dividends of $0.50 on its 8% Cumulative Redeemable Preferred Stock, $0.492188 on Class B Series 1, $0.443750 on Class B Reset Rate Series 2, $0.421875 on Class B Reset Rate Series 3, and $0.468750 on Class B Series 4, each on $25.00 per share preferred stock. These dividends are payable on June 30, 2026 to shareholders of record as of June 15, 2026, and the notice is made in line with Nasdaq Listing Rule 5250(e)(6)(ii) and SEC Rule 10b–17.
CHS Inc. announced that director Daniel Schurr resigned from its Board of Directors effective March 30, 2026, after accepting a seat on the board of Nationwide Mutual Insurance Company. He had served on the CHS Board since 2006 and was Board Chair from 2017 to December 2025.
Mr. Schurr represented Region 7, which includes Alabama, Arkansas, Florida, Georgia, Iowa, Louisiana, Mississippi, Missouri, North Carolina, South Carolina and Tennessee. A new Region 7 Director will be elected by CHS members at the 2026 CHS Annual Meeting.